Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Regeneus Ltd. (AU:RGS)
ASX:RGS
Regeneus Ltd. (RGS) Share Price & Analysis
1 Followers
RGS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.02
Previous CloseAU$0.01
Volume13.89K
Average Volume (3M)N/A
Market Cap
AU$1.53M
Enterprise ValueAU$2.38M
Total Cash (Recent Filing)AU$164.40K
Total Debt (Recent Filing)AU$1.01M
Price to Earnings (P/E)-1.5
Beta-0.95
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding306,436,914
10 Day Avg. Volume235,232
30 Day Avg. VolumeN/A
Standard Deviation0.21
R-Squared0.00010
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
17.47%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
82.53% Public Companies and
Individual Investors
RGS FAQ
What was Regeneus Ltd.’s price range in the past 12 months?
Regeneus Ltd. lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Regeneus Ltd.’s market cap?
Currently, no data Available
When is Regeneus Ltd.’s upcoming earnings report date?
Regeneus Ltd.’s upcoming earnings report date is Aug 29, 2024 which is in 123 days.
How were Regeneus Ltd.’s earnings last quarter?
Regeneus Ltd. released its earnings results on Feb 29, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Regeneus Ltd. overvalued?
According to Wall Street analysts Regeneus Ltd.’s price is currently Overvalued.
Does Regeneus Ltd. pay dividends?
Regeneus Ltd. does not currently pay dividends.
What is Regeneus Ltd.’s EPS estimate?
Regeneus Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regeneus Ltd. have?
Regeneus Ltd. has 306,436,920 shares outstanding.
What happened to Regeneus Ltd.’s price movement after its last earnings report?
Regeneus Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Regeneus Ltd.?
Currently, no hedge funds are holding shares in AU:RGS
---
Regeneus Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-93.46%
Trailing 12-Months
Company Description
Regeneus Ltd.
Regeneus Ltd clinical-stage regenerative medicine company. It mainly develops a portfolio of cell-based therapies to address significant unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases. The company uses stem cell and immuno-oncology technologies to develop cell-based therapies. Its product pipeline consists of two platform technologies, Progenza and Sygenus, across three target therapeutic areas namely osteoarthritis, neuropathic pain, and skin wound healing.
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Alcidion Group Limited
―
OncoSil Medical Ltd
―
Genetic Signatures Ltd.
―
---